{"nct_id":"NCT03769467","title":"Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)","status":"TERMINATED","status_verified_date":"2024-09","start_date":"2019-02-19","start_date_type":"ACTUAL","primary_completion_date":"2021-08-19","primary_completion_date_type":"ACTUAL","completion_date":"2021-08-19","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["ATRA"]}